Neurocrine(NBIX) - 2025 Q2 - Earnings Call Transcript

Neurocrine Biosciences (NBIX) Q2 2025 Earnings Call July 30, 2025 04:30 PM ET Company ParticipantsTodd Tushla - VP - IRKyle Gano - President, CEO & DirectorMatt Abernethy - CFOEric Benevich - CCOSanjay Keswani - Chief Medical OfficerPhilip Nadeau - MD, Health Care – BiotechnologyEiry Roberts - Strategic Advisor to CEO - (CMO Emerita)Paul Matteis - Managing Director, Head of Therapeutics ResearchCory Kasimov - Senior Managing DirectorBrian Abrahams - MD & Co-Head of Biotechnology ResearchCorinne Johnson - Vi ...